Trxade Health Common Stock

As of the most recent data (September 2026), MEDS shows a common stock of $470. That compares with $230 in the prior-year period — up 104.8% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, MEDS's common stock is now $470 (was $230) — a 104.8% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Trxade Health is outperforming or lagging.

Tracking MEDS's common stock over time shows whether Trxade Health is scaling, shrinking, or reshaping that part of the business. The current reading is $470 That compares with $230 in the prior-year period — up 104.8% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this common stock page, Stockcircle has Trxade Health's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect common stock (currently $470) with ownership activity and broader fundamentals.

Trxade Health's common stock is $470; compare it with other Finance names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.